Central Asian Chlor-Alkali & Chemicals Manufacturing Platform
EBITDA
$186,000,000
Gross
$620,000,000
OTTIENI UNA VALUTAZIONE GRATUITA IN 24 ORE CLICK HERE X Dismiss
Global lower-middle market M&A Advisors
Countries in which we've closed transactions
Languages spoken by our Team
Total deals value
Global lower-middle market M&A Advisors
Countries in which we've closed transactions
Languages spoken by our Team
Total deals value
© 2026 MergersCorp M&A International.
© 2025 MergersCorp M&A International is a global brand operating through a number of professional firms and constituent entities (“Members”) located throughout the world to provide Investment Banking, Corporate Finance, and Advisory Services and other client-related professional services. The Member Firms (“Members”) are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit our Disclaimer: https://mergerscorp.com/disclaimer. MergersCorp M&A International's franchising program is not offered to individuals or entities located in the United States.
The franchising program is offered by MergersUK Limited, a UK Company with its registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom.
MergersCorp M&A International provides strategic business advisory services, including preparing companies for growth and capital access. Through partnerships with licensed investment bankers, clients can access tailored capital-raising solutions.
U.S. Investment Banking Securities transactions are exclusively conducted by Spektrum Capital Advisors LLC, a Registered Representative of, and Securities Products offered through, BA Securities, LLC, a FINRA-registered broker-dealer. Check the background of investment professionals associated with this site on Broker Check.
The proposed project entails the development of a state-of-the-art, vertically integrated chlor-alkali and downstream specialty chemical manufacturing cluster in Kazakhstan. Capitalizing on abundant domestic salt reserves, compe ...
A leading independent multi-omics service providers in the Americas. The Company provides a comprehensive portfolio of next-generation sequencing (NGS), proteomics, metabolomics, epigenomics, and bioinformatics solutions to resear ...
The Company is a well-established Italian manufacturer and distributor of specialty chemical products, with a long-standing heritage rooted in post-war industrial development. Over decades, the business has evolved into a recogniz ...
US company owns producer and processors Tier 3 licenses in Washington state. 49,000 sq ft building (where the Flower room is 11,500 sq. ft. and Mather and Veg is 7,700 sq. ft.) is currently finished on this (10 acres) site. ...
The business was born in 2017 from the idea of nine members who came from different fields but shared the same passion for hemp and its boundless worlds. After opening the first official shop in the same year, several openings fol ...
The company was founded in the district Punjab India, 1982 with a purpose of manufacturing Active Pharmaceutical Ingredients. The company is an active pharmaceutical ingredient (API) manufacturing company that manufactures the ...
This company for sale is a healthcare company based in Bangalore, India. The business is involved in the manufacturing and supply of medicines and nutritional supplements to people across the globe (Quality standards as specified ...
| Metric | Target Value |
| Total Capital Expenditure (CapEx) | US$1.06 Billion |
| Project Net Present Value (NPV) | US$62.2 Million |
| Internal Rate of Return (IRR) | 15.2% |
| Simple Payback Period | 5.7 Years |
| Discounted Payback Period | 9.1 Years |
| Primary Target Markets | Kazakhstan, Uzbekistan, Kyrgyzstan, Tajikistan, Turkmenistan |
Line Item Amount (US$ M) % of Revenue Strategic Notes Gross Revenue $620.0 100.0% Blended sales: bulk chlor-alkali + premium downstream (PVC, resins, surfactants) Raw Materials & Feedstock ($148.8) 24.0% Domestic salt advantage, ethylene/petrochem inputs, catalysts Power & Utilities ($161.2) 26.0% Chlor-alkali electrolysis power intensity Direct Labor & Plant O&M ($49.6) 8.0% Specialized chemical operators, regular turnaround maintenance Logistics & Distribution ($37.2) 6.0% Rail/road freight across Central Asia & Middle Corridor Cost of Goods Sold (COGS) ($396.8) 64.0% Total direct manufacturing costs Gross Profit $223.2 36.0% SG&A and Corporate Overheads ($37.2) 6.0% Commercial team, compliance, licensing, regional distribution offices EBITDA $186.0 30.0% ~5.7x CapEx/EBITDA multiple (aligns with 5.7-yr simple payback) Depreciation & Amortization (D&A) ($53.0) 8.5% Straight-line asset depreciation (~20-year operational life) EBIT (Operating Income) $133.0 21.5% Net Financing Costs ($38.0) 6.1% Indicative 60:40 debt-to-equity leverage structure Earnings Before Taxes (EBT) $95.0 15.3% Corporate Income Tax ($19.0) 3.1% Statutory 20% CIT rate (excl. potential SEZ tax incentives) Net Income $76.0 12.3%
© 2025 MergersCorp M&A International is a global brand operating through a number of professional firms and constituent entities (“Members”) located throughout the world to provide Investment Banking, Corporate Finance, and Advisory Services and other client-related professional services. The Member Firms (“Members”) are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit our Disclaimer: https://mergerscorp.com/disclaimer. MergersCorp M&A International's franchising program is not offered to individuals or entities located in the United States.
The franchising program is offered by MergersUK Limited, a UK Company with its registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom.
MergersCorp M&A International provides strategic business advisory services, including preparing companies for growth and capital access. Through partnerships with licensed investment bankers, clients can access tailored capital-raising solutions.
U.S. Investment Banking Securities transactions are exclusively conducted by Spektrum Capital Advisors LLC, a Registered Representative of, and Securities Products offered through, BA Securities, LLC, a FINRA-registered broker-dealer. Check the background of investment professionals associated with this site on Broker Check.
This website is operated by MergersUS Inc a US Corporation with registered office at




